3 days popular7 days popular1 month popular3 months popular

In Non-Small Cell Lung Cancer Resection, Statins May Help Prolong Survival

Patients who have undergone resection for () may improve their overall survival and reduce the risk of recurrence by taking statins.

Researchers from , Chicago, and followed 803 patients who underwent resection for NSCLC, of which 315 were using statins. Results showed that statin use was associated with a significantly lower local and significantly higher overall survival compared with non-statin users.

Researchers conclude that prospective studies are needed to assess the role of statin therapy as an adjunct to current multimodality regimens.


This study was presented during CHEST 2012, the annual meeting of the , held October 20 – 25, in Atlanta, Georgia.
American College of Chest Physicians